JPMorgan says there's a new GLP-1 drug player and it can rally 80%
Structure Therapeutics could one day boast a competitive obesity product and go up against Eli Lilly and the like, according to JPMorgan.
Source: cnbc.com
Stay updated with breaking news from Hardik Parikh. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Structure Therapeutics could one day boast a competitive obesity product and go up against Eli Lilly and the like, according to JPMorgan.
MRK earnings call for the period ending March 31, 2023.